High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05585151
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT05585151
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05585151. Randomized; no masking; primary purpose treatment. Start 2022-11-09 (actual); primary completion 2024-04-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study
- Condition
- Cerebral Atherosclerosis
- Intervention (Drug)
- Evolocumab 140 MG/ML
- Intervention (Drug)
- Intensive statin treatment
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Record details
- Record id
cardio:ct-nct05585151- Content hash
f3a0f351bc573b596141c5e083ac54bb861e7f206b5f0d1ea81e8b9fb87632c3